Applications of Modeling and Simulation (M&S) in Cardiac Safety Studies
Why are modeling and simulation important in cardiac safety? How are they different? In this presentation from the October 2009 DIA webinar on cardiac safety, Dr. Giri Tirucherai makes a compelling case for using both modeling and simulation in early product development to leverage data from early clinical studies to design optimal TQT studies. Learn how this approach provides a broader, more comprehensive assessment of a drug’s pro-arrhythmic potential.
